3,3-Dimethyl-7-nitro-2,3-dihydrobenzo[b][1,4]oxazepin-4(5h)-one, 95%, 250mg

Ethyl 6-bromobenzo[d]isoxazole-3-carboxylate, 95.0%, 250mg

4-Bromo-3,3,4,4-tetrafluorobutene-1, 97.0%, 1g

Ethyl 4-methyl-1H-pyrazole-5-carboxylate, 95.0%, 10g

1-(3-PHENOXYPHENYL)ETHANONE, 95.0%, 1g

4-Aminoquinoline-2-one, 95.0%, 100mg

3,4-Difluoro-2-((2-fluoro-4-iodophenyl)amino)-N-(2-hydroxyethoxy)benzamide, 95%, 1g

6-Methoxypyridazin-4-amine, 98%, 250mg

Matraces aforados con tapón de vidrio, clase A Vidrio transparente, 50 ml, 14/23, 2 Unidad(es)

3-METHYL-4,5,6,7-TETRAHYDRO-2H-INDAZOLE-5-CARBOXYLIC ACID, 95.0%, 250mg

3-Bromo-2-fluoroiodobenzene, 99.5%, 10g

Methyl 7-chloro-3-hydroxybenzo[b]thiophene-2-carboxylate, 97.0%, 100mg

Methyl 3-chloro-6-oxo-1,6-dihydropyridine-2-carboxylate, 95.0%, 1g